Avadel Pharmaceuticals plc(AVDL) - 2023 Q3 - Quarterly Results
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 8, 2023 AVADEL PHARMACEUTICALS PLC (Exact name of registrant as specified in its charter) Ireland 001-37977 98-1341933 (State or other jurisdiction (Commission (IRS Employer of incorporation) File Number) Identification No.) 10 Earlsfort Terrace Dublin 2, Ireland, D02 T380 Not ...